Global Radiodermatitis Market Size, Trends, & Growth Opportunity by Product (Oral, Dressings), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, and Forecast till 2027.
Global Radiodermatitis Market
The global radiodermatitis market was valued at USD 4362.5 million in 2021 which is expected to reach USD 674.22 million by 2027, at a CAGR 9.09 % from 2022-2027.
Radiation dermatitis, X-ray dermatitis, and radiation injury are all names for radiodermatitis. It is an unintended consequence of external beam ionising radiation. Radiotherapy is used to treat cancer or other disorders, which is the most common cause of radiothermatitis.
Market Drivers
The rise in cancer prevalence is the primary driving factor projected to increase the worldwide radiodermatitis market's growth. For example, the American Cancer Society estimates that in 2019, around 1,762,450 cancer cases will be identified and approximately 606,880 cancer deaths will occur in the United States. Furthermore, increased research & development of new medicines for radiodermatitis therapy will positively benefit global radiodermatitis market growth. Furthermore, investments in raising awareness about radiation-induced skin damage are likely to fuel the worldwide radiodermatitis market's expansion.
Market Restraints
However, the high cost of dressings such as honey-impregnated dressing and silicone dressing is projected to limit the worldwide radiodermatitis market's growth.
Market Segmentation
Global Radiodermatitis Market is segmented into products such as topical (corticosteroids, hydrophilic creams, antibiotics, and others), Oral, and Dressings (No Sting barrier film, Silicone Coated dressings, Honey impregnated gauze, and Others). Further, Global Radiodermatitis Market is segmented into distribution channel such as Hospital Pharmacy, Retail Pharmacy, and Others.
Regional analysis
Also, Global Radiodermatitis Market is segmented into five regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
Market Key Players
Various key players are discussed in this report, such as Jay Pharma, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., Molnlycke Health Care, Intermed Pharmaceuticals, DermaSciences, Inc., ConvaTec Group PLC, BMG Pharma S.r.l., and Acelity, Inc. (3M).
Market Taxonomy
By Product
- Topical
- Corticosteroids
- Hydrophilic Creams
- Antibiotics
- Others
- Oral
- Dressings
- No Sting barrier film
- Silicone Coated dressings
- Honey impregnated gauze
- Others
- Hospital Pharmacy
- Retail Pharmacy
- Others
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- 1 Introduction
- 1.1 Objectives of the Study
- 1.2 Market definition
- 1.3 Market scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Radiodermatitis Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porter's Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Radiodermatitis Market, By Product
- 5.1 Y-o-Y Growth Comparison, By Product
- 5.2 Global Radiodermatitis Market Share Analysis, By Product
- 5.3 Global Radiodermatitis Market Size and Forecast, By Product
- 5.3.1 Topical
- 5.3.1.1 Corticosteroids 5.3.1.2Hydrophillic Creams
- 5.3.1.3Antibiotics
- 5.3.1.4Others
- 5.3.2 Oral
- 5.3.3Dressings
- 5.3.3.1No String barrier film
- 5.3.3.2 Silicone Coated dressings
- 5.3.3.3 Honey-impregnated gauze
- 5.3.3.4Others
- 6 Global Radiodermatitis Market, By Distribution Channel
- 6.1 Y-o-Y Growth Comparison, By Distribution Channel
- 6.2 Global Radiodermatitis Market Share Analysis, By Distribution Channel
- 6.3 Global Radiodermatitis Market Size and Forecast, By Distribution Channel
- 6.3.1 Hospital Pharmacy
- 6.3.2 Retail Pharmacy
- 6.3.3 Others
- 7Global Radiodermatitis Market, By Region
- 7.1 Global Radiodermatitis Market Share Analysis, By Region
- 7.2 Global Radiodermatitis Market Share Analysis, By Region
- 7.3 Global Radiodermatitis Market Size and Forecast, By Region
- 8 North America Radiodermatitis Market Analysis and Forecast (2022–2027)
- 8.1 Introduction
- 8.2 North America Radiodermatitis Market Share Analysis, By Product
- 8.3 North America Radiodermatitis Market Size and Forecast, By Distribution Channel
- 8.4 North America Radiodermatitis Market Size and Forecast, By Country
- 8.4.1 U.S.
- 8.4.2 Canada
- 8.4.3 Mexico
- 9Europe Radiodermatitis Market Analysis and Forecast (2022 – 2027)
- 9.1 Introduction
- 9.2 Europe Radiodermatitis Market Share Analysis, By Product
- 9.3 Europe Radiodermatitis Market Size and Forecast, By Distribution Channel
- 9.4 Europe Radiodermatitis Market Size and Forecast, By Country
- 9.4.1 Germany
- 9.4.2 France
- 9.4.3 UK
- 9.4.4. Rest of Europe
- 10 Asia Pacific Radiodermatitis Market Analysis and Forecast (2022–2027)
- 10.1 Introduction
- 10.2 Asia Pacific Radiodermatitis Market Share Analysis, By Product
- 10.3 Asia Pacific Radiodermatitis Market Size and Forecast, By Distribution Channel
- 10.4 Asia Pacific Radiodermatitis Market Size and Forecast, By Country
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4. Rest of Asia Pacific
- 11Latin America Radiodermatitis Market Analysis and Forecast (2022 – 2027)
- 11.1 Introduction
- 11.2 Latin America Radiodermatitis Market Share Analysis, By Product
- 11.3 Latin America Radiodermatitis Market Size and Forecast, By Distribution Channel
- 11.4 Latin America Radiodermatitis Market Size and Forecast, By Country
- 12 Middle East Radiodermatitis Market Analysis and Forecast (2022 – 2027)
- 12.1 Introduction
- 12.2 Middle East Radiodermatitis Market Share Analysis, By Product
- 12.3 Middle East Radiodermatitis Market Size and Forecast, By Distribution Channel
- 12.4 Middle East Radiodermatitis Market Size and Forecast, By Country
- 13Competitive Analysis
- 13.1 Competition Dashboard
- 13.2 Market share Analysis of Top Vendors
- 13.3 Key Development Strategies
- 14Company Profiles
- 15.1 Jay Pharma
- 15.1.1 Overview
- 15.1.2 Offerings
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2 Smith & Nephew Plc
- 15.2.1 Overview
- 15.2.2 Offerings
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3 Stratpharma AG
- 15.3.1 Overview
- 15.3.2 Offerings
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 Kannalife, Inc.
- 15.4.1 Overview
- 15.4.2 Offerings
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 Molnlycke Health Care
- 15.5.1 Overview
- 15.5.2 Offerings
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 Intermed Pharmaceuticals
- 15.6.1 Overview
- 15.6.2 Offerings
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
- 15.7 DermaSciences, Inc.
- 15.7.1 Overview
- 15.7.2 Offerings
- 15.7.3 Key Financials
- 15.7.4 Business Segment & Geographic Overview
- 15.7.5 Key Market Developments
- 15.7.6 Key Strategies
- 15.8 ConvaTec Group PLC
- 15.8.1 Overview
- 15.8.2 Offerings
- 15.8.3 Key Financials
- 15.8.4 Business Segment & Geographic Overview
- 15.8.5 Key Market Developments
- 15.8.6 Key Strategies
- 15.9 BMG Pharma S.r.l.
- 15.9.1 Overview
- 15.9.2 Offerings
- 15.9.3 Key Financials
- 15.9.4 Business Segment & Geographic Overview
- 15.9.5 Key Market Developments
- 15.9.6 Key Strategies
- 15.10 Acelity, Inc. (3M)
- 15.10.1 Overview
- 15.10.2 Offerings
- 15.10.3 Key Financials
- 15.10.4 Business Segment & Geographic Overview
- 15.10.5 Key Market Developments
- 15.10.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook